Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)
| 12.00 Delayed Data As of 3:59pm ET |  -0.18 / -1.48%Today’s Change | 7.36 Today|||52-Week Range 15.25 | +1.95% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | -- | -- |
| Depreciation And Amortization | 22.0K | 28.0K | 286.0K | -- | ||
| Operating Expenses | Gross Income | -22.0K | -28.0K | -286.0K | -- | |
| General Expenses | 24.0M | 65.4M | 107.9M | -- | ||
| Research And Development | 17.4M | 56.4M | 86.6M | -- | ||
| Total Operating Expenses | 24.0M | 65.4M | 108.2M | -- | ||
| Non-Operating Expenses | Operating Income | -24.0M | -65.4M | -108.2M | -- | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -23.9M | -64.9M | -103.4M | -- | |
| Income Taxes | -36.0K | -2.0K | -214.0K | -- | ||
| Net Income | -24.0M | -64.9M | -103.2M | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 49.7M | 49.7M | 29.5M | -- | |
| Shares To Calculate EPS Diluted | 49.7M | 49.7M | 29.5M | -- | ||
| Earnings Per Share | EPS | -$0.48 | -$1.31 | -$3.49 | -- | |
| EPS Diluted | -$0.48 | -$1.31 | -$3.49 | -- | ||
